Xiaoping Qing

1.4k total citations
23 papers, 1.1k citations indexed

About

Xiaoping Qing is a scholar working on Immunology, Infectious Diseases and Oncology. According to data from OpenAlex, Xiaoping Qing has authored 23 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 6 papers in Infectious Diseases and 6 papers in Oncology. Recurrent topics in Xiaoping Qing's work include Virus-based gene therapy research (6 papers), Viral Infections and Outbreaks Research (6 papers) and T-cell and B-cell Immunology (6 papers). Xiaoping Qing is often cited by papers focused on Virus-based gene therapy research (6 papers), Viral Infections and Outbreaks Research (6 papers) and T-cell and B-cell Immunology (6 papers). Xiaoping Qing collaborates with scholars based in United States, Canada and Switzerland. Xiaoping Qing's co-authors include Chaim Putterman, Jane E. Salmon, Bisram Deocharan, Juan Javier Lichauco, Patricia Redecha, Milena Pitashny, Carl Blobel, Tak W. Mak, Priya D. Issuree and Thorsten Maretzky and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Xiaoping Qing

22 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xiaoping Qing United States	15	540	390	237	217	199	23	1.1k
A Fukatsu Japan	20	324 0.6×	205 0.5×	273 1.2×	139 0.6×	225 1.1×	41	1.1k
Hiroko Nagafuchi Japan	25	495 0.9×	564 1.4×	298 1.3×	120 0.6×	53 0.3×	60	1.5k
S Aotsuka Japan	22	464 0.9×	635 1.6×	182 0.8×	103 0.5×	95 0.5×	64	1.2k
Roberto Bullani Switzerland	10	307 0.6×	386 1.0×	317 1.3×	229 1.1×	48 0.2×	14	1.3k
Jack Hutcheson United States	22	654 1.2×	246 0.6×	461 1.9×	303 1.4×	65 0.3×	37	1.3k
Nobuya Yoshida United States	22	964 1.8×	555 1.4×	301 1.3×	204 0.9×	79 0.4×	38	1.4k
Lihua Bao United States	22	900 1.7×	384 1.0×	256 1.1×	77 0.4×	652 3.3×	49	1.6k
Kazuya Takasawa Japan	15	419 0.8×	274 0.7×	197 0.8×	248 1.1×	463 2.3×	27	1.3k
Tsai-Hung Wu Taiwan	14	323 0.6×	301 0.8×	196 0.8×	74 0.3×	128 0.6×	32	710
Vilma Urbonaviciute Germany	16	941 1.7×	273 0.7×	361 1.5×	88 0.4×	50 0.3×	29	1.3k

Countries citing papers authored by Xiaoping Qing

Since Specialization

Citations

This map shows the geographic impact of Xiaoping Qing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoping Qing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoping Qing more than expected).

Fields of papers citing papers by Xiaoping Qing

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoping Qing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoping Qing. The network helps show where Xiaoping Qing may publish in the future.

Co-authorship network of co-authors of Xiaoping Qing

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoping Qing. A scholar is included among the top collaborators of Xiaoping Qing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoping Qing. Xiaoping Qing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ho, Alan L., Lisle Nabell, Prakash Neupane, et al.. (2024). HB-200 arenavirus-based immunotherapy plus pembrolizumab as first-line treatment of patients with recurrent/metastatic HPV16-positive head and neck cancer: Updated results.. Journal of Clinical Oncology. 42(16_suppl). 6005–6005. 5 indexed citations

Fu, Siqing, Lisle M. Nabell, Alexander T. Pearson, et al.. (2022). Recommended phase 2 dose (RP2D) of HB-200 arenavirus-based cancer immunotherapies in patients with HPV16+ cancers.. Journal of Clinical Oncology. 40(16_suppl). 2517–2517. 3 indexed citations

Lauterbach, Henning, Sarah Schmidt, Xiaoping Qing, et al.. (2021). Development and Characterization of a Novel Non-Lytic Cancer Immunotherapy Using a Recombinant Arenavirus Vector Platform. Frontiers in Oncology. 11. 732166–732166. 15 indexed citations

Ho, Alan L., Marshall R. Posner, Jiaxin Niu, et al.. (2021). First report of the safety/tolerability and preliminary antitumor activity of HB-201 and HB-202, an arenavirus-based cancer immunotherapy, in patients with HPV16+ cancers.. Journal of Clinical Oncology. 39(15_suppl). 2502–2502. 5 indexed citations

Zhan, Wenhu, Pradeep K. Singh, Yi Ban, et al.. (2020). Structure–Activity Relationships of Noncovalent Immunoproteasome β5i-Selective Dipeptides. Journal of Medicinal Chemistry. 63(21). 13103–13123. 11 indexed citations

Schmidt, Sarah, Weldy V. Bonilla, Andrea Reiter, et al.. (2020). Live-attenuated lymphocytic choriomeningitis virus-based vaccines for active immunotherapy of HPV16-positive cancer. OncoImmunology. 9(1). 1809960–1809960. 13 indexed citations

Qing, Xiaoping, Yurii Chinenov, Patricia Redecha, et al.. (2018). iRhom2 promotes lupus nephritis through TNF-α and EGFR signaling. Journal of Clinical Investigation. 128(4). 1397–1412. 67 indexed citations

Shipman, William, Susan Chyou, Anusha Ramanathan, et al.. (2018). A protective Langerhans cell–keratinocyte axis that is dysfunctional in photosensitivity. Science Translational Medicine. 10(454). 54 indexed citations

Qing, Xiaoping, Lindsay D. Rogers, Arthur Mortha, et al.. (2016). iRhom2 regulates CSF1R cell surface expression and non‐steady state myelopoiesis in mice. European Journal of Immunology. 46(12). 2737–2748. 16 indexed citations

10.

Issuree, Priya D., Thorsten Maretzky, David R. McIlwain, et al.. (2013). iRHOM2 is a critical pathogenic mediator of inflammatory arthritis. Journal of Clinical Investigation. 123(2). 928–32. 128 indexed citations

11.

Vukelic, Milena, Xiaoping Qing, Patricia Redecha, Gloria C. Koo, & Jane E. Salmon. (2013). Cholinergic Receptors Modulate Immune Complex–Induced Inflammation In Vitro and In Vivo. The Journal of Immunology. 191(4). 1800–1807. 22 indexed citations

12.

Qing, Xiaoping, Gloria C. Koo, & Jane E. Salmon. (2012). Complement regulates conventional DC‐mediated NK‐cell activation by inducing TGF‐β1 in Gr‐1⁺ myeloid cells. European Journal of Immunology. 42(7). 1723–1734. 14 indexed citations

13.

Andrade, Danieli, Patricia Redecha, Milena Vukelic, et al.. (2011). Engraftment of peripheral blood mononuclear cells from systemic lupus erythematosus and antiphospholipid syndrome patient donors into BALB‐RAG‐2^−/−IL‐2Rγ^−/− mice: A promising model for studying human disease. Arthritis & Rheumatism. 63(9). 2764–2773. 51 indexed citations

14.

Pawar, Rahul D., Milena Pitashny, Béatrice Goilav, et al.. (2011). Neutrophil gelatinase–associated lipocalin is instrumental in the pathogenesis of antibody‐mediated nephritis in mice. Arthritis & Rheumatism. 64(5). 1620–1631. 42 indexed citations

15.

Qing, Xiaoping, Patricia Redecha, Melissa A. Burmeister, et al.. (2010). Targeted inhibition of complement activation prevents features of preeclampsia in mice. Kidney International. 79(3). 331–339. 71 indexed citations

16.

Qing, Xiaoping, Milena Pitashny, David B. Thomas, et al.. (2008). Pathogenic anti-DNA antibodies modulate gene expression in mesangial cells: Involvement of HMGB1 in anti-DNA antibody-induced renal injury. Immunology Letters. 121(1). 61–73. 66 indexed citations

17.

Pitashny, Milena, Noa Schwartz, Xiaoping Qing, et al.. (2007). Urinary lipocalin‐2 is associated with renal disease activity in human lupus nephritis. Arthritis & Rheumatism. 56(6). 1894–1903. 108 indexed citations

18.

Qing, Xiaoping, Jiří Zavadil, Michelle B. Crosby, et al.. (2006). Nephritogenic Anti‐DNA antibodies regulate gene expression in MRL/lpr mouse glomerular mesangial cells. Arthritis & Rheumatism. 54(7). 2198–2210. 68 indexed citations

19.

Qing, Xiaoping & Chaim Putterman. (2004). Gene expression profiling in the study of the pathogenesis of systemic lupus erythematosus. Autoimmunity Reviews. 3(7-8). 505–509. 39 indexed citations

20.

Deocharan, Bisram, Xiaoping Qing, Juan Javier Lichauco, & Chaim Putterman. (2002). α-Actinin Is a Cross-Reactive Renal Target for Pathogenic Anti-DNA Antibodies. The Journal of Immunology. 168(6). 3072–3078. 168 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact